Enhanced PON1 activity in the kidneys of cyclophosphamide treated rats may play a protective role as an antioxidant against cyclophosphamide induced oxidative stress

Archives of Toxicology

Volumn 82, Issue 4, 2008, Pages 237-238

  Abraham, Premila ^a   Sugumar, Emila ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Cyclophosphamide; PON1 activity; Rat; Renal damage

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CYCLOPHOSPHAMIDE; GLUTATHIONE; KIDNEY ENZYME; MALONALDEHYDE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVITY; FEMALE; KIDNEY INJURY; LIPID OXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; CYCLOPHOSPHAMIDE; FEMALE; KIDNEY; KIDNEY DISEASES; OXIDATIVE STRESS; RATS;

RATTUS;

EID: 43349087374     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-007-0240-3     Document Type: Article

References (10)

1. Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE (2003) Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers 8:1-12 Review
2. Costa LG, Cole TB, Furlong CE (2005) Paraoxonase (PON1): from toxicology to cardiovascular medicine. Acta Biomed 76(Suppl 2):50-57
3. Dollery C (1999) Cyclophosphamide. In: Dollery C (ed) Therapeutic drugs. Churchill Livingstone, Edinburgh, pp 349-353
4. Ellman GL (1959) Tissue sulphydryl groups. Arch Biochem Biophys 82:70-77
5. Gur M, Aslan M, Yildiz A, Demirbag R, Yilmaz R, Selek S, Erel O, Ozdogru I (2006) Paraoxonase and aryl esterase activities in coronary artery disease. Eur J Clin Invest 36:779-787
6. Manda K, Bhatia AL (2003) Prophylatic action of melatonin against cyclophosphamide induced oxidative stress in mice. Cell Biol Toxicol 19:367-372
7. Ohkawa H, Oshini N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric reaction. Anal Biochem 95:351-358
8. Takahashi Y, Aoyama F, Ito F, YamamuraY (1967) Evaluation of phenyl acetate esterase activity as an index of liver damage. Clin Chim Acta 18:21-32
9. Tsuzura S, Ikeda Y, Suehiro T, Ota K, Osaki F, Arii K, Kumon Y, Hashimoto K (2004) Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 53:297-302
10. Vasdev S, Gill V, Singal PK (2006) Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms. Vasc Health Risk Manag 2:263-276